Lam Research Corporation
LRCX scores 71.9 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.
Moderate penalties (-8.3 points) reflect identified risk factors. The overall score balances these against the stock's fundamental strengths.
These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.
No risk factors identified.
| Stock | Score | P/E | Rev Growth | Margin | Mkt Cap |
|---|---|---|---|---|---|
| LRCX | 71.9 | 48.3 | 23.7% | 29.1% | $295.8B |
| MPWR | 84.8 | 91.7 | 21.2% | 81.0% | $57.1B |
| ZM | 84.2 | 18.0 | 3.1% | 21.7% | $27.7B |
| NVDA | 80.6 | 45.2 | 114.2% | 55.8% | $4.5T |
| CRUS | 79.7 | 19.1 | 6.0% | 17.5% | $7.4B |
| ASML | 77.8 | 48.1 | 15.6% | 29.4% | $546.0B |
| IDCC | 77.4 | 31.8 | -4.0% | 48.8% | $9.7B |
| CSCO | 77.1 | 27.6 | 5.3% | 18.0% | $303.6B |
| RMBS | 75.5 | 48.3 | 20.7% | 32.3% | $11.0B |
| DBX | 75.3 | 13.9 | 1.9% | 17.7% | $6.4B |
| FSLR | 75.0 | 17.3 | 26.7% | 30.7% | $24.2B |
| SIMO | 74.7 | 9.2 | 10.2% | 13.8% | $4.5B |
| ADI | 74.3 | 74.1 | 16.9% | 20.6% | $165.1B |
| AAPL | 72.5 | 33.1 | 6.4% | 27.0% | $3.9T |
| OLED | 72.5 | 27.0 | 12.4% | 34.3% | $5.9B |
| AMAT | 72.3 | 36.4 | 4.4% | 24.7% | $281.7B |
| Sector Average | 47.4 | 87.4 | 14.8% | -109.6% | â |
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Stock is in an uptrend above the 200-day moving average. This is the stage where institutional accumulation typically occurs. The 50-day SMA provides support.
| Metric | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Revenue | $5.3B | $5.3B | $5.2B | $4.7B |
| Gross Profit | $2.7B | $2.7B | $2.6B | $2.3B |
| Operating Income | $1.8B | $1.8B | $1.7B | $1.6B |
| Net Income | $1.6B | $1.6B | $1.7B | $1.3B |
| EPS (Diluted) | $1.26 | $1.24 | $1.35 | $1.03 |
| Gross Margin | 49.6% | 50.4% | 50.1% | 49.0% |
| Operating Margin | 33.9% | 34.4% | 33.7% | 33.1% |
| Net Margin | 29.8% | 29.5% | 33.3% | 28.2% |
| Year | Low | High | Range | Status |
|---|---|---|---|---|
| 2021 | $50.17 | $72.84 | 36.9% | Wide |
| 2022 | $29.96 | $73.18 | 83.8% | Wide |
| 2023 | $40.73 | $80.13 | 65.2% | Wide |
| 2024 | $68.87 | $113.00 | 48.5% | Wide |
| 2025 | $56.32 | $179.80 | 104.6% | Wide |
Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.